![]() |
| Optimer Pharmaceuticals Announces Positive Results in Pruli |
|
RSS FEED
|
SAN DIEGO----Optimer Pharmaceuticals, Inc. today announced positive results from its first double-blind Phase 3 trial assessing the safety and efficacy of Prulifloxacin as a once-daily , three-day oral therapy for infectious diarrhea. Read more... |
||||||||||||
|
|
|||||||||||||
| Optimer Pharmaceuticals Announces Positive Results in Pruli |
|
||
|
Site Map
|
Sitemap |

